CollabRx Announces Special Meeting of Its Stockholders to Be Held October 28, 2015
GlobeNewswire - Thu Sep 24, 5:00PM CDT
CollabRx, Inc. ("CollabRx"
CLRX: 0.59 (-0.01)
Medytox Solutions, Inc. Announces New Board Members
Marketwired - Thu Aug 13, 10:00AM CDT
Medytox Solutions, Inc. announces the election of two new board members who boast years of professional leadership in corporate governance, financial services, company restructuring, and healthcare. Michael L. Goldberg, managing director of Monarch Capital, LLC, and Robert Lee, managing partner of Sheffield Investment Partners, joined returning board members Christopher E. Diamantis, chairman and CEO of Integrated Financial Settlements, Inc.; Benjamin Frank, a retired lawyer and businessman with experience in healthcare, foreign trade, retail, business development, and government; and Seamus Lagan, CEO of Medytox Solutions, Inc. The election took place at the annual stockholders' meeting of Medytox Solutions, Inc. on August 6, 2015.
July Brings Winning Streak Of Massive Cash Jackpots To Table Mountain Casino Players Club Members
PR Newswire - Mon Jul 20, 7:13PM CDT
Reel luck and huge winnings have Table Mountain Casino Club Members getting their win on as yet another random Massive Cash Jackpot paid out again--the third one in a string of BIG jackpots to hit.
CollabRx Announces Receipt of NASDAQ Notice of Noncompliance for Bid Price
GlobeNewswire - Fri Jun 05, 6:00AM CDT
CollabRx, Inc. (Nasdaq:CLRX) (herein "CLRX" or "the Company"
CLRX: 0.59 (-0.01)
InsiderInsights.com Daily Round Up 6/1/15: Unwired Planet, GoPro, Impac Mortgage Holdings And Halcon Resources
InsiderInsights - at Seeking Alpha - Tue Jun 02, 12:53PM CDT
UCP: 7.02 (-0.05), GPRO: 29.08 (+1.48), HK: 0.97 (-0.03), CUBI: 24.58 (-0.27), ASPS: 29.52 (-0.18), ADMS: 15.66 (+0.24), LLY: 86.14 (+2.37), GOOG: 643.61 (+4.45), AMH: 16.72 (-0.03), CME: 88.30 (-1.58), LBF: 7.92 (+0.06), NVAX: 8.04 (+0.43), WRI: 34.32 (-0.16), AXTA: 27.08 (-0.32), IMH: 18.18 (-0.71), SPLK: 58.21 (+1.84), UPIP: 0.72 (unch), CMLS: 0.76 (+0.01)
Table Mountain Casino's Massive Cash Jackpot Pays Yet Another Lucky Winner
PR Newswire - Mon Jun 01, 6:32PM CDT
Table Mountain Casino's Lucky Club member, Gurdial of Fresno, visited his favorite casino, Table Mountain, and left with a mountain of money! The popular Massive Cash jackpot randomly paid out on the machine he was playing, showering him with $100,604.82 in cold hard cash!
CollabRx Receives Notice From Nasdaq on Change of Control
GlobeNewswire - Wed Apr 29, 6:01AM CDT
CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx" or "the Company"
CLRX: 0.59 (-0.01)
CollabRx and Medytox Solutions Sign Definitive Merger Agreement
GlobeNewswire - Thu Apr 16, 6:00AM CDT
CollabRx, Inc. (Nasdaq:CLRX) ("CollabRx"
CLRX: 0.59 (-0.01)
Medytox Solutions Signs Definitive Merger Agreement With CollabRx
GlobeNewswire - Thu Apr 16, 6:00AM CDT
Medytox Solutions, Inc. (OTCQB:MMMS) ("Medytox"
CLRX: 0.59 (-0.01)
Integrated Healthcare Company, Medytox Solutions, Inc., Names New COO
Marketwired - Wed Feb 18, 10:00AM CST
Medytox Solutions, Inc. (OTCBB: MMMS), which owns and operates clinical laboratories and healthcare technology companies, announced today that it named Samuel R. Mitchell, Jr., chief operating officer. As COO, Mr. Mitchell will work to streamline performance throughout the Medytox family of companies headquartered in West Palm Beach. He will also oversee quarterly and annual financial goal management.
CollabRx announces non-binding letter of intent for proposed business combination with Medytox Solutions
M2 - Fri Jan 23, 8:03PM CST
Medical information company CollabRx (NasdaqCM:CLRX) reported on Thursday the execution of a non-binding letter of intent to negotiate a potential business combination with Medytox Solutions (OTCBB:MMMS).
CLRX: 0.59 (-0.01)
CollabRx and Medytox Solutions Sign Non-Binding Letter of Intent for Possible Business Combination
Marketwired - Thu Jan 22, 5:30AM CST
CollabRx, Inc. (NASDAQ: CLRX) and Medytox Solutions, Inc. (OTCQB: MMMS) ("Medytox"
CLRX: 0.59 (-0.01)
Medytox Diagnostics' International Technologies awarded the New York State Department's Health Clinical Laboratory permit
M2 - Thu Jan 08, 4:53AM CST
Medytox Diagnostics stated on Wednesday that its New Jersey-based laboratory, International Technologies, has been certified with a Clinical Laboratory Permit by the New York State Department of Health.
Medytox Diagnostics Awarded License to Begin Lab Testing in New York State
Marketwired - Wed Jan 07, 10:06AM CST
The New York State Department of Health awarded Medytox Diagnostics, Inc.'s New Jersey-based laboratory, International Technologies, LLC, with a Clinical Laboratory Permit that allows the lab to begin servicing clients throughout New York State with a full continuum of laboratory services, including sophisticated drug screening. Medytox Diagnostics, a subsidiary of Medytox Solutions, Inc. (OTCBB: MMMS), has carved a niche serving the drug testing needs of substance abuse facilities and pain management practices at its New Jersey lab and its network of laboratories nationwide.
CORRECTION - Medytox Billing Subsidiary Expands Patient Relations Department
Marketwired - Tue Dec 30, 9:00AM CST
In the news release, "Medytox Billing Subsidiary Expands Patient Relations Department," issued Wednesday, December 24, 2014 by Medytox Solutions, Inc. (OTCBB: MMMS), we are advised by the company that the fourth paragraph should read "William DePond, M.D., COO of Medytox Diagnostics, Inc., and CEO of Medytox-owned laboratories" rather than "William DePond, M.D., COO of Medytox Solutions, Inc., and CEO of Medytox laboratories" as originally issued. Complete corrected text follows.
Medytox Billing Subsidiary Expands Patient Relations Department
Marketwired - Wed Dec 24, 9:30AM CST
Medical Billing Choices, Inc., a subsidiary of Medytox Solutions, Inc., has created a new Patient Relations department to assist the growing number of patients served through Medytox-owned laboratories with the patient responsibility portion of claims generated for services. Medytox's network of laboratories provides a full continuum of laboratory and clinical testing services, including sophisticated drug screening, on behalf of physicians and facilities nationwide.
Fast-Growing Chain of Labs, Medytox Diagnostics, Announces CEO of Laboratories
Marketwired - Wed Dec 17, 10:21AM CST
Medytox Diagnostics, Inc., which owns and operates half a dozen clinical laboratories throughout the U.S., announced today it named William DePond, M.D., CEO of Medytox laboratories. In his role, Dr. DePond will oversee the company's expanding network of toxicology labs that specialize in drug screening and analysis for substance abuse facilities and the ongoing drug screening required for patients of pain management physicians.
Florida-Based Health Technology Company Hires Specialized PR and Marketing Firm
Marketwired - Wed Nov 19, 2:34PM CST
The Weinbach Group, a marketing communications firm with expertise in healthcare-related public relations and advertising, announced today that Medytox Solutions, Inc. (OTCBB: MMMS) selected the Miami public relations firm to build recognition for the West Palm Beach-based health technology company. Medytox, which has recently completed a number of strategic acquisitions, anticipates continued M&A activity into 2015. It will utilize The Weinbach Group to raise visibility among prospective targets for acquisition, capital sources, and industry decision makers who use services provided by Medytox' family of companies.